Publications by authors named "Gerald Luscan"

Claim this Profile
E
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.
Carlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese, Kevin R Kelly, Vivian G Oehler, Gerald Luscan

Leukemia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
Jennifer Hammond, Carla Yunis, Robert J Fountaine, Gerald Luscan, Aimee M Burr

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
Lisa Vermunt, Graciela Muniz-Terrera, Lea Ter Meulen, Colin Veal, Kaj Blennow, Gerald Luscan

Alzheimers Res Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
Lisa Vermunt, Colin D Veal, Lea Ter Meulen, Charalambos Chrysostomou, Wiesje van der Flier, Gerald Luscan

Alzheimers Dement· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies.
Adrian Ivanoiu, Jérémie Pariente, Kevin Booth, Kasia Lobello, Gerald Luscan

Alzheimers Res Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials.
Rik Vandenberghe, Juha O Rinne, Mercè Boada, Sadao Katayama, Philip Scheltens, Gerald Luscan

Alzheimers Res Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis